Importantly, we show that >95% of tumor-specific CD8+ T cells in the postimmunotherapy tumor-draining lymph node express high levels of IL-7R, which is otherwise sparsely expressed in the lymph node by nonantigen-specific cells. This evidence concerns the gene CD8A and neoplasm.